Rachelle Tutterrow
Family · Indianapolis, INNPI 1437699410
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,844 of the $2,212 with a category attached, or 83.4%. It is spread thinly across 32 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations.
Across 127 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$311
- Pharmacyclics LLC, An Abbvie Company$228
- Incyte Corporation$225
- Novartis$172
- AbbVie$161
- Seagen Inc.$151
- plus $965 from 26 others
What the payments were for
- Food & beverage$1,84483%
- Education$36817%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $311 |
| Pharmacyclics LLC, An Abbvie Company | 9 | $228 |
| Incyte Corporation | 9 | $225 |
| Novartis | 14 | $172 |
| AbbVie | 5 | $161 |
| Seagen Inc. | 7 | $151 |
| Merck | 7 | $117 |
| Johnson & Johnson(2 entities) | 6 | $91 |
| Daiichi Sankyo Inc. | 4 | $70 |
| Eisai Inc. | 4 | $65 |
| AstraZeneca | 4 | $58 |
| Puma Biotechnology, Inc. | 4 | $56 |
| Boehringer Ingelheim | 3 | $48 |
| Exelixis Inc. | 3 | $45 |
| GSK | 2 | $38 |
| Sanofi | 2 | $37 |
| Acceleron Pharma, Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Pharmacosmos Therapeutics Inc. | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Beigene USA, Inc. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $20 |
| Dova Pharmaceuticals | 1 | $20 |
| Gilead | 1 | $16 |
| Pfizer | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| Bayer | 1 | $13 |
| Karyopharm Therapeutics Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $11 |
How this compares
$2,212 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.